Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC Inhibitors.

Qu K, Zaba LC, Satpathy AT, Giresi PG, Li R, Jin Y, Armstrong R, Jin C, Schmitt N, Rahbar Z, Ueno H, Greenleaf WJ, Kim YH, Chang HY.

Cancer Cell. 2017 Jul 10;32(1):27-41.e4. doi: 10.1016/j.ccell.2017.05.008. Epub 2017 Jun 15.

2.

Individuality and variation of personal regulomes in primary human T cells.

Qu K, Zaba LC, Giresi PG, Li R, Longmire M, Kim YH, Greenleaf WJ, Chang HY.

Cell Syst. 2015 Jul 29;1(1):51-61.

3.

CARD14 expression in dermal endothelial cells in psoriasis.

Harden JL, Lewis SM, Pierson KC, Suárez-Fariñas M, Lentini T, Ortenzio FS, Zaba LC, Goldbach-Mansky R, Bowcock AM, Lowes MA.

PLoS One. 2014 Nov 4;9(11):e111255. doi: 10.1371/journal.pone.0111255. eCollection 2014.

4.

Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position.

Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ.

Nat Methods. 2013 Dec;10(12):1213-8. doi: 10.1038/nmeth.2688. Epub 2013 Oct 6.

5.

TREM-1 as a potential therapeutic target in psoriasis.

Hyder LA, Gonzalez J, Harden JL, Johnson-Huang LM, Zaba LC, Pierson KC, Eungdamrong NJ, Lentini T, Gulati N, Fuentes-Duculan J, Suárez-Fariñas M, Lowes MA.

J Invest Dermatol. 2013 Jul;133(7):1742-51. doi: 10.1038/jid.2013.68. Epub 2013 Feb 13.

6.

Skin disease in dermatomyositis.

Zaba LC, Fiorentino DF.

Curr Opin Rheumatol. 2012 Nov;24(6):597-601. Review.

PMID:
22907594
7.

A subpopulation of CD163-positive macrophages is classically activated in psoriasis.

Fuentes-Duculan J, Suárez-Fariñas M, Zaba LC, Nograles KE, Pierson KC, Mitsui H, Pensabene CA, Kzhyshkowska J, Krueger JG, Lowes MA.

J Invest Dermatol. 2010 Oct;130(10):2412-22. doi: 10.1038/jid.2010.165. Epub 2010 Jun 17.

8.

Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis.

Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Johnson-Huang LM, Nograles KE, White TR, Pierson KC, Lentini T, Suárez-Fariñas M, Lowes MA, Krueger JG.

J Allergy Clin Immunol. 2010 Jun;125(6):1261-1268.e9. doi: 10.1016/j.jaci.2010.03.018. Epub 2010 May 14.

9.

Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA).

Suárez-Fariñas M, Lowes MA, Zaba LC, Krueger JG.

PLoS One. 2010 Apr 20;5(4):e10247. doi: 10.1371/journal.pone.0010247.

10.

Atopic dermatitis keratinocytes exhibit normal T(H)17 cytokine responses.

Nograles KE, Suárez-Fariñas M, Shemer A, Fuentes-Duculan J, Chiricozzi A, Cardinale I, Zaba LC, Kikuchi T, Ramon M, Bergman R, Krueger JG, Guttman-Yassky E.

J Allergy Clin Immunol. 2010 Mar;125(3):744-6, 746.e1-746.e2. doi: 10.1016/j.jaci.2009.12.934. No abstract available.

11.

Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes.

Zaba LC, Suárez-Fariñas M, Fuentes-Duculan J, Nograles KE, Guttman-Yassky E, Cardinale I, Lowes MA, Krueger JG.

J Allergy Clin Immunol. 2009 Nov;124(5):1022-10.e1-395. doi: 10.1016/j.jaci.2009.08.046.

12.

IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.

Nograles KE, Zaba LC, Shemer A, Fuentes-Duculan J, Cardinale I, Kikuchi T, Ramon M, Bergman R, Krueger JG, Guttman-Yassky E.

J Allergy Clin Immunol. 2009 Jun;123(6):1244-52.e2. doi: 10.1016/j.jaci.2009.03.041. Epub 2009 May 12.

13.

Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation.

Bluth MJ, Zaba LC, Moussai D, Suárez-Fariñas M, Kaporis H, Fan L, Pierson KC, White TR, Pitts-Kiefer A, Fuentes-Duculan J, Guttman-Yassky E, Krueger JG, Lowes MA, Carucci JA.

J Invest Dermatol. 2009 Oct;129(10):2451-62. doi: 10.1038/jid.2009.96. Epub 2009 Apr 23.

14.

Dendritic cells in the pathogenesis of sarcoidosis.

Zaba LC, Smith GP, Sanchez M, Prystowsky SD.

Am J Respir Cell Mol Biol. 2010 Jan;42(1):32-9. doi: 10.1165/rcmb.2009-0033TR. Epub 2009 Apr 16. Review.

15.

Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis.

Guttman-Yassky E, Lowes MA, Fuentes-Duculan J, Zaba LC, Cardinale I, Nograles KE, Khatcherian A, Novitskaya I, Carucci JA, Bergman R, Krueger JG.

J Immunol. 2008 Nov 15;181(10):7420-7.

16.

Resident and "inflammatory" dendritic cells in human skin.

Zaba LC, Krueger JG, Lowes MA.

J Invest Dermatol. 2009 Feb;129(2):302-8. doi: 10.1038/jid.2008.225. Epub 2008 Aug 14. Review.

17.

Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.

Nograles KE, Zaba LC, Guttman-Yassky E, Fuentes-Duculan J, Suárez-Fariñas M, Cardinale I, Khatcherian A, Gonzalez J, Pierson KC, White TR, Pensabene C, Coats I, Novitskaya I, Lowes MA, Krueger JG.

Br J Dermatol. 2008 Nov;159(5):1092-102. doi: 10.1111/j.1365-2133.2008.08769.x. Epub 2008 Aug 5.

18.

Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells.

Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Abello MV, Novitskaya I, Pierson KC, Gonzalez J, Krueger JG, Lowes MA.

J Invest Dermatol. 2009 Jan;129(1):79-88. doi: 10.1038/jid.2008.194. Epub 2008 Jul 17.

19.

A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci.

Liu Y, Helms C, Liao W, Zaba LC, Duan S, Gardner J, Wise C, Miner A, Malloy MJ, Pullinger CR, Kane JP, Saccone S, Worthington J, Bruce I, Kwok PY, Menter A, Krueger J, Barton A, Saccone NL, Bowcock AM.

PLoS Genet. 2008 Mar 28;4(3):e1000041. doi: 10.1371/journal.pgen.1000041.

20.

Identification of cellular pathways of "type 1," Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis.

Haider AS, Lowes MA, Suárez-Fariñas M, Zaba LC, Cardinale I, Khatcherian A, Novitskaya I, Wittkowski KM, Krueger JG.

J Immunol. 2008 Feb 1;180(3):1913-20.

21.

Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells.

Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, Bowman EP, Krueger JG.

J Invest Dermatol. 2008 May;128(5):1207-11. doi: 10.1038/sj.jid.5701213. Epub 2008 Jan 17.

22.

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses.

Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Suárez-Fariñas M, Fuentes-Duculan J, Novitskaya I, Khatcherian A, Bluth MJ, Lowes MA, Krueger JG.

J Exp Med. 2007 Dec 24;204(13):3183-94. Epub 2007 Nov 26. Erratum in: J Exp Med. 2008 Aug 4;205(8):1941. Suárez Fariñas, Mayte [corrected to Suárez-Fariñas, Mayte].

23.

Insights into gene modulation by therapeutic TNF and IFNgamma antibodies: TNF regulates IFNgamma production by T cells and TNF-regulated genes linked to psoriasis transcriptome.

Haider AS, Cohen J, Fei J, Zaba LC, Cardinale I, Toyoko K, Ott J, Krueger JG.

J Invest Dermatol. 2008 Mar;128(3):655-66. Epub 2007 Oct 11.

24.

Cellular genomic maps help dissect pathology in human skin disease.

Haider AS, Lowes MA, Suàrez-Fariñas M, Zaba LC, Cardinale I, Blumenberg M, Krueger JG.

J Invest Dermatol. 2008 Mar;128(3):606-15. Epub 2007 Oct 11.

25.

Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages.

Zaba LC, Fuentes-Duculan J, Steinman RM, Krueger JG, Lowes MA.

J Clin Invest. 2007 Sep;117(9):2517-25.

Supplemental Content

Support Center